Actively Enrolling Clinical Trials

Share:

If you would like more information about one of our studies please e-mail deneva.zamora@houstonretina.com or call 713-524-3434.

If there is a specific trial you are interested in please contact the study specific coordinator.


Wet Age-Related Macular Degeneration Trials 


ALLERGAN CEDAR

A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com
Study Coordinator (Woodlands): Stacy Supapo, stacy.supapo@houstonretina.com


GX28228 (LADDER)

Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Participants With Subfoveal Neovascular Age-Related Macular Degeneration

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Cassie Cone, cassandra.cone@houstonretina.com


ALLERGAN SAPLING

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With NeovasCular AMD

 

For additional information on this trial, click here.

 

Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com


Geographic Atrophy & Dry Age-Related Macular Degeneration Trials


 

OPH2003

 

A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 

 

For additional information on this trial, click here.

 

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com

Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com

 


Diabetic Macular Edema


HULK 

Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com
Study Coordinator (Katy): Chelsey Moore, chelsey.moore@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com

 


Non-Proliferative Diabetic Macular Edema


REGENERON 1411 (PANORAMA)

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR) 

For additional information on this trial, click here.

Study Coordinator (Medical Center): JoLene Carranza, jolene.carranza@houstonretina.com
Study Coordinator (Woodlands): Stacy Supapo, stacy.supapo@houstonretina.com


DRCR PROTOCOL W 

Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy

For additional information on this trial, click here.

Study Coordinator (Medical Center): Amy Hutson, amy.hutson@houstonretina.com
Study Coordinator (Woodlands): Stacy Supapo, stacy.supapo@houstonretina.com


Proliferative Diabetic Retinopathy


RECOVERY

Intravitreal Aflibercept for Retina Non-Perfustion in Proliferative Diabetic Retinopathy

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center & Space Center): Amy Hutson amy.hutson@houstonretina.com
Study Coordinator (Katy & Kingwood): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com


Retinal Vein Occlusion


SAPPHIRE

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion

 For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): JoLene Carranza, jolene.carranza@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com


Uveitis


CLS1001-302 (Azalea)

A Phase 3, Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients with Non-infectious Uveitis

Additional information on this trial coming soon.

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com
Study Coordinator (Woodlands): Melisa Bocanegra, melisa.bocanegra@houstonretina.com


CLS1001-301 (PEACHTREE)

A Phase 3, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects With Macular Edema Associated With Non-infectious Uveitis

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com
Study Coordinator (Woodlands): Melisa Bocanegra, melisa.bocanegra@houstonretina.com


POINT 

PeriOcular and Intravitreal Corticosteroids for Uveitic Macular Edema Trial (POINT)

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com


MERIT

Macular Edema Ranibizumab v. Intravitreal Anti-Inflammatory Therapy Trial

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Chelsey Moorechelsey.moore@houstonretina.com


  Choroidal Nevi & Melanoma


BAP1

Identification of Germline BAP1 Mutation in Patients with Choroidal Nevi and Uveal Melanoma

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Katy): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Woodlands): Melisa Bocanegra, melisa.bocanegra@houstonretina.com


 

Radiation Retinopathy


RRR

A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined with Targeted Retinal Photocoagulation in Subjects with Radiation Retinopathy

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Katy): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Woodlands): Melisa Bocanegra, melisa.bocanegra@houstonretina.com


ARRT

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial

For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): Cassie Conecassandra.cone@houstonretina.com
Study Coordinator (Katy): Cassie Cone, cassandra.cone@houstonretina.com
Study Coordinator (Woodlands): Melisa Bocanegra, melisa.bocanegra@houstonretina.com

 


 

Retinal Vein Occlusion


Sapphire

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion

 For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): JoLene Caranza, jolene.carranza@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yeerebecca.yee@houstonretina.com

 


 

Retinal Vein Occlusion


Sapphire

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion

 For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): JoLene Caranza, jolene.carranza@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yeerebecca.yee@houstonretina.com

 


 

Retinal Vein Occlusion


Sapphire

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following Retinal Vein Occlusion

 For additional information on this trial, click here.

Study Coordinator (Texas Medical Center): JoLene Caranza, jolene.carranza@houstonretina.com
Study Coordinator (Woodlands): Rebecca Yeerebecca.yee@houstonretina.com

OPH2003

A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 

 

For additional information on this trial, click here.

 

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com

Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com

OPH2003

A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration 

 

For additional information on this trial, click here.

 

Study Coordinator (Texas Medical Center): Chelsey Moore, chelsey.moore@houstonretina.com

Study Coordinator (Woodlands): Rebecca Yee, rebecca.yee@houstonretina.com